To test whether inhibition of GPT can suppress β-catenin–driven HCC development that was accelerated by loss of GS, GPT1 was successfully silenced by an sgRNA (Figure 8A), which significantly reduced the tumor burden in Glul-KO livers (Figure 8, B and C). Here, GLUL is linked to neoplasm.